Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Robot suit aims to boost walking in kids with cerebral palsy

NCT ID NCT07146932

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests a wearable robotic exoskeleton called Bambini Teens in 20 children aged 5 to 14 with cerebral palsy. The device assists leg movement during walking training. Researchers will check if it is safe and easy to use, and if it improves walking speed after six 30-minute sessions over about three weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Bambini Teens Exoskeleton (wearable robotic device)
What this could lead to
If it works, this could provide a new gait training tool to improve walking ability in children with cerebral palsy.
What could go wrong
This is a very small early trial with only 20 participants, so results may not apply to all children. The device may not improve walking or could cause discomfort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 20 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2025

An estimate. Start dates often move.

Expected to finish

Jan 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

5 to 14 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Between the age of 5 and 14 years and diagnosed with cerebral palsy; * have joint range of motion within normal functional limits for ambulation as determined by study staff; * Be able and willing to comply with study procedures, including follow-up requirements; * Patient cognitive status and ability to communicate must be at a level consistent with that required to participate in standard motor rehabilitation; * can follow directions as determined by study staff; * be able to physically fit into exoskeleton device; height from 110 to 160 cm (43 to 62 inches) and weighing up less than 65 kg (145 lbs); * be able to walk 10 meters with the aid of a walking assistive device and/or a single human assistant; * bilateral lower limb spasticity that allows lower limb range of motion within the device. Exclusion Criteria: * any medical issue that precludes full weight-bearing and ambulation (e.g. orthopedic injuries, pain, severe spasticity); * skin issues that would prevent wearing the device; * pre-existing condition that caused exercise intolerance; * uncontrolled seizure disorder, spasticity or joint contracture that would interfere with walking; * neuromuscular, neurological, cardiovascular or orthopedic pathologies that will interfere with neuromuscular function, ambulation, or limit the range of motion of the lower limbs; * severe spasticity (Modified Ashworth Scale = or \> 3); * hip extension range of motion \< 0 degrees, knee flexion contracture \> 20 degrees, knee valgus \> 40 degrees, 2 or more fractures within the past year, hip subluxation (\> 40% migration), * existing Baclofen pump, and/or Botox injections within the past 4 months of study enrollment;

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cerebral palsy (CP) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Kessler Foundation

    West Orange, New Jersey, 07052, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.